Hepatitis C
Conditions
Brief summary
Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.
Detailed description
Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.
Interventions
None listed
Sponsors
US Department of Veterans Affairs
Study design
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Ever initiated anitiviral treatment for hepatitis C.
Exclusion criteria
none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Attributes of Treatment Experience | Zero to five years since ending treatment. | Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Group 1 patients who initiated antiviral treatment for hepatitis C | 21 |
| Total | 21 |
Baseline characteristics
| Characteristic | Group 1 |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 1 Participants |
| Age, Categorical Between 18 and 65 years | 20 Participants |
| Age, Continuous | 57 years |
| Region of Enrollment United States | 21 participants |
| Sex: Female, Male Female | 1 Participants |
| Sex: Female, Male Male | 20 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | — / — |
| other Total, other adverse events | 0 / 21 |
| serious Total, serious adverse events | 0 / 21 |
Outcome results
Primary
Attributes of Treatment Experience
Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.
Time frame: Zero to five years since ending treatment.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Group 1 | Attributes of Treatment Experience | Avoid Bad End | 14 participants |
| Group 1 | Attributes of Treatment Experience | Perseverence | 15 participants |
| Group 1 | Attributes of Treatment Experience | Achieve Cure | 7 participants |
| Group 1 | Attributes of Treatment Experience | Redemption | 9 participants |